164 related articles for article (PubMed ID: 36593711)
1. Effect of Metformin on Lower Urinary Tract Symptoms in Male Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study in Taiwan.
Tseng CH
World J Mens Health; 2023 Jul; 41(3):680-691. PubMed ID: 36593711
[TBL] [Abstract][Full Text] [Related]
2. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
3. The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin.
Tseng CH
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259372
[TBL] [Abstract][Full Text] [Related]
4. Metformin Use Is Associated With a Lower Incidence of Hospitalization for Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus.
Tseng CH
Front Med (Lausanne); 2020; 7():592901. PubMed ID: 33693008
[No Abstract] [Full Text] [Related]
5. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
[No Abstract] [Full Text] [Related]
6. Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study.
Tseng CH
Front Endocrinol (Lausanne); 2022; 13():1036885. PubMed ID: 36277720
[TBL] [Abstract][Full Text] [Related]
7. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study.
Tseng CH
World J Mens Health; 2023 Jan; 41(1):119-128. PubMed ID: 35274506
[TBL] [Abstract][Full Text] [Related]
10. Dementia Risk in Type 2 Diabetes Patients: Acarbose Use and Its Joint Effects with Metformin and Pioglitazone.
Tseng CH
Aging Dis; 2020 May; 11(3):658-667. PubMed ID: 32489710
[TBL] [Abstract][Full Text] [Related]
11. Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Front Pharmacol; 2020; 11():578831. PubMed ID: 33664665
[No Abstract] [Full Text] [Related]
12. Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients.
Tseng CH
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242462
[TBL] [Abstract][Full Text] [Related]
13. Metformin reduces risk of varicose veins in patients with type 2 diabetes.
Tseng CH
Diabetes Metab Res Rev; 2020 Feb; 36(2):e3206. PubMed ID: 31322821
[TBL] [Abstract][Full Text] [Related]
14. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
Tseng CH
J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
[TBL] [Abstract][Full Text] [Related]
15. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
Tseng CH
Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Analysis.
Tseng CH
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30262775
[TBL] [Abstract][Full Text] [Related]
17. Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
Tseng CH
Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1389-1400. PubMed ID: 36939574
[TBL] [Abstract][Full Text] [Related]
18. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
Chin-Hsiao T
Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
[TBL] [Abstract][Full Text] [Related]
19. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
[TBL] [Abstract][Full Text] [Related]
20. Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.
Tseng CH
Front Oncol; 2020; 10():587666. PubMed ID: 33194743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]